By integrating the transcriptome data from clinical specimens, in vitro, and in vivo approaches, we unveiled the importance and therapeutic potential of the regulatory mechanisms of CXCR7 on CXCL12 in glioblastoma cells, which consequently affected GAM induction and T-cell alteration. The gene discussed is ACKR3; the disease is glioblastoma.